Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octenidine vs Chlorhexidine for Postoperative Pain in Endodontics
NCT07173725Completed
- Sponsor
- Bezmialem Vakif University
- Start
- Mar 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Randomised, triple-blind trial of octenidine in apical periodontitis (AP) (2 arms), sponsored by Bezmialem Vakif University. Primary endpoint: Postoperative Pain at 48 hours. Started Mar 2023; status: completed.
02
Drugs
octenidine
03
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on NCT07173725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07173725.